Revelyst, Inc.

As of September 30, 2024, Revelyst, Inc. has 58.38M shares outstanding.

As of September 30, 2024, Revelyst, Inc. trades at an EV/EBITDA multiple of 4.45 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.07 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Revelyst, Inc. trades at an EV/FCF ratio of 0.68, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of September 30, 2024, Revelyst, Inc. maintains a current ratio of 2.52, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended September 30, 2024, Revelyst, Inc. posted a negative return on equity (ROE) of -245,926.67, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -117.75, reflecting losses generated across the asset base. Inventory turnover of 18.17 indicates how many times Revelyst, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended September 30, 2024. That works out to an effective tax rate of 0.74, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended September 30, 2024, Revelyst, Inc. posted a gross margin of 29.68, reflecting its pricing power and cost economics. The operating margin of -4.04 and net profit margin of -18.71 provide insight into operational efficiency.

As of September 30, 2024, Revelyst, Inc. has an Altman Z-Score of 1.99, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.